Zensun is a biopharmaceutical company focused on the development of innovative ‘first in class’ bio-therapeutic products for the treatment of serious and life-threatening unmet medical needs. We discover new medicines using novel disease specific targets and innovative technologies. The patented discoveries are then developed into therapies. With adherence to the tenet of “healing for life”, we hope to transform the lives of heart failure and cancer patients by providing them with drugs that treat their disease and not just the symptoms. This is our purpose, this is our passion and this is our promise.
To meet the world's highest standards, incorporate international intelligence and expand the coverage of patients who are waiting to benefit from our discoveries, Zensun USA Inc. was established to conduct clinical trials, manufacture and distribute our new products. As a globalized biotech company, Zensun has gathered experts and pioneers from around the world, and attracted investors with a forward vision and broad outlook. Zensun leverages the leading technology to best serve our patients and deliver maximum return for investors.